._老虎社区_美港股上老虎

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":861979908,"tweetId":"861979908","gmtCreate":1632452042704,"gmtModify":1632722226764,"author":{"id":3576861864918846,"idStr":"3576861864918846","authorId":3576861864918846,"authorIdStr":"3576861864918846","name":"Rdhilly","avatar":"https://static.tigerbbs.com/d00424543e3f5db74636158d0166cd42","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>.</p></body></html>","htmlText":"<html><head></head><body><p>.</p></body></html>","text":".","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/861979908","repostId":2169698119,"repostType":4,"repost":{"id":"2169698119","kind":"highlight","pubTimestamp":1632450780,"share":"https://ttm.financial/m/news/2169698119?lang=&edition=full","pubTime":"2021-09-24 10:33","market":"us","language":"en","title":"Why Novavax Stock Is Jumping Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2169698119","media":"Motley Fool","summary":"There were two positive news stories for the biotech on Thursday.","content":"<h2>What happened</h2>\n<p>Shares of <b>Novavax</b> (NASDAQ:NVAX) were jumping 9.7% as of 10:48 a.m. EDT on Thursday. There were a couple of catalysts for the stock.</p>\n<p>Novavax and its partner, Serum Institute of India, announced Thursday morning that they have filed for World Health Organization emergency use listing of Novavax's COVID-19 vaccine. Also, data from a late-stage clinical study conducted in the U.K. of the vaccine were published in The New England Journal of Medicine. This data showed that Novavax's vaccine achieved an efficacy of 89.7%.</p>\n<h2>So what</h2>\n<p>Neither of today's developments was a surprise. However, they were both positive for Novavax and motivated some investors to pile back into the vaccine stock.</p>\n<p>Of the two stories, the EUL filing is the more important for Novavax. An EUL from the WHO is needed to export vaccines to countries that participate in the COVAX Facility. Novavax CEO Stanley Erck stated, \"Today's submission of our protein-based COVID-19 vaccine to WHO for emergency use listing is a significant step on the path to accelerating access and more equitable distribution to countries in great need around the world.\"</p>\n<h2>Now what</h2>\n<p>It's uncertain how long the WHO will take to complete its review of Novavax's and SII's EUL filing. In the meantime, investors can look forward to several other key milestones. Novavax is preparing to file for emergency use authorizations in several countries, including the U.K., Canada, Australia, New Zealand, the European Union, and the U.S.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Is Jumping Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Is Jumping Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-24 10:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/23/why-novavax-stock-is-jumping-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of Novavax (NASDAQ:NVAX) were jumping 9.7% as of 10:48 a.m. EDT on Thursday. There were a couple of catalysts for the stock.\nNovavax and its partner, Serum Institute of India, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/23/why-novavax-stock-is-jumping-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/09/23/why-novavax-stock-is-jumping-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169698119","content_text":"What happened\nShares of Novavax (NASDAQ:NVAX) were jumping 9.7% as of 10:48 a.m. EDT on Thursday. There were a couple of catalysts for the stock.\nNovavax and its partner, Serum Institute of India, announced Thursday morning that they have filed for World Health Organization emergency use listing of Novavax's COVID-19 vaccine. Also, data from a late-stage clinical study conducted in the U.K. of the vaccine were published in The New England Journal of Medicine. This data showed that Novavax's vaccine achieved an efficacy of 89.7%.\nSo what\nNeither of today's developments was a surprise. However, they were both positive for Novavax and motivated some investors to pile back into the vaccine stock.\nOf the two stories, the EUL filing is the more important for Novavax. An EUL from the WHO is needed to export vaccines to countries that participate in the COVAX Facility. Novavax CEO Stanley Erck stated, \"Today's submission of our protein-based COVID-19 vaccine to WHO for emergency use listing is a significant step on the path to accelerating access and more equitable distribution to countries in great need around the world.\"\nNow what\nIt's uncertain how long the WHO will take to complete its review of Novavax's and SII's EUL filing. In the meantime, investors can look forward to several other key milestones. Novavax is preparing to file for emergency use authorizations in several countries, including the U.K., Canada, Australia, New Zealand, the European Union, and the U.S.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2106,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/861979908"}